Ignite Creation Date:
2024-05-05 @ 11:45 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00127777
Status:
UNKNOWN
Last Update Posted:
2005-08-25
First Post:
2005-08-04
Brief Title:
Peginterferon Alfa-2a Ribavirin AmantadinePlacebo in Hepatitis C Virus HCV-Genotype-1-Infection PRAMA
Sponsor:
University Hospital Saarland
Organization:
University Hospital Saarland
Organization Data
Organization:
University Hospital Saarland
Class:
OTHER
Study ID:
ML17002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University Hospital Saarland
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Hoffmann-La Roche | INDUSTRY |